Curis Lifesciences Confirms Corporate Governance Report Exemption for Q2 FY27
Curis Lifesciences Ltd 路 Others (Uncategorized) 路 19 Oct 2026, 10:22 pm
Curis Lifesciences Confirms Corporate Governance Report Exemption for Q2 FY27 Curis Lifesciences Limited has confirmed the non-applicability of Corporate Governance Report submission under Regulation 27(2) of SEBI LODR Regulations for the quarter and half-year ended 30th Sep'26. Being listed on the NSE SME platform (NSE Emerge), the company is exempt under Regulation 15(2)(b) from key corporate governance provisions, excluding Regulation 23 compliance where applicable. A practicing company secretary certificate from Sachin Thakkar & Associates has been submitted confirming this regulatory exemption.
Original exchange filing (PDF)
More announcements from Curis Lifesciences Ltd
- Curis Lifesciences Limited has informed the Exchange regarding 'Standalone andconsolidated financials results for the half year ended on 30th September, 2026'. 路 16 Nov 2026
- Curis Lifesciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 路 11 Nov 2026
- Curis Lifesciences Limited has submitted to the Exchange, the standalone and consolidated financial results for the half year ended September 30, 2026. 路 11 Nov 2026
- Curis Lifesciences Limited has informed the Exchange about Board Meeting to be held on 11-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 11 Nov 2026
- Curis Lifesciences Limited has informed the Exchange about the Board meeting to be held on 11th November, 2026 to consider and approve the unaudited Standalone and Consolidated financial results for the half year ended on September 30, 2026 路 11 Nov 2026
- Curis Lifesciences Limited has submitted the Exchange a copy Srutinizers report of 10th Annual General Meeting held on September 29, 2026. Further, the company has informed the Exchange regarding voting results. 路 01 Oct 2026
- CURIS: Curis Lifesciences Limited has informed the Exchange regarding Proceedings of 10thAnnual General Meeting held on September 29, 2026. 路 30 Sept 2026
- Curis Lifesciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2026 路 08 Sept 2026
